Alejandro F De Nicola Selected Research

ST 1435

1/2021	Progress in progestin-based therapies for neurological disorders.
11/2014	Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alejandro F De Nicola Research Topics

Disease

15	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 12/2002
14	Gliosis 01/2022 - 12/2002
9	Multiple Sclerosis 01/2021 - 11/2007
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 01/2008
7	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 01/2008
6	Neuroinflammatory Diseases 01/2022 - 10/2011
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 04/2011
5	Inflammation (Inflammations) 01/2022 - 10/2007
4	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2020 - 12/2002
4	Neuralgia (Stump Neuralgia) 03/2016 - 01/2011
4	Hypertension (High Blood Pressure) 09/2013 - 01/2004
4	Ischemia 08/2012 - 12/2002
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2009 - 12/2002
3	Nervous System Diseases (Neurological Disorders) 01/2021 - 02/2007
3	Stroke (Strokes) 01/2021 - 12/2011
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 10/2007
3	Atrophy 01/2020 - 02/2007
3	Ischemic Stroke 01/2017 - 10/2007
3	Chronic Pain 03/2016 - 01/2011
3	Pain (Aches) 03/2016 - 01/2011
3	Hypertensive Encephalopathy 02/2015 - 04/2008
2	Brain Diseases (Brain Disorder) 07/2020 - 02/2015
2	Hypertrophy 01/2020 - 09/2014
2	Hyperalgesia 01/2016 - 01/2011
2	Motor Neuron Disease (Primary Lateral Sclerosis) 12/2013 - 12/2002
2	Wounds and Injuries (Trauma) 12/2010 - 11/2007
2	Brain Injuries (Brain Injury) 07/2009 - 07/2006
1	Sclerosis 01/2022
1	Congenital Abnormalities (Deformity) 01/2020
1	Fatigue 01/2020
1	Endometriosis 01/2019
1	Hyperplasia 01/2018
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2015
1	Myelitis 11/2015
1	Essential Hypertension 02/2015
1	Contusions 05/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2012

Drug/Important Bio-Agent (IBA)

29	Progesterone FDA LinkGeneric 01/2022 - 12/2002
13	Messenger RNA (mRNA)IBA 01/2019 - 08/2002
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
11	SteroidsIBA 11/2016 - 07/2006
7	Estradiol (Delestrogen)FDA LinkGeneric 02/2015 - 07/2006
7	Estrogens (Estrogen)FDA Link 02/2015 - 08/2002
6	Hormones (Hormone)IBA 07/2020 - 12/2002
6	NeurosteroidsIBA 11/2018 - 06/2004
6	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2015 - 02/2005
5	Neuroprotective AgentsIBA 01/2022 - 02/2007
5	GlucocorticoidsIBA 03/2020 - 02/2009
5	EnzymesIBA 11/2018 - 02/2015
5	Streptozocin (Streptozotocin)FDA Link 02/2009 - 12/2002
3	Progestins (Progestagens)IBA 01/2021 - 08/2013
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 11/2014
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 03/2020 - 02/2009
3	CorticosteroneIBA 01/2020 - 09/2014
3	SaltsIBA 12/2010 - 01/2004
2	Toll-Like Receptor 4IBA 01/2022 - 01/2018
2	Pregnanolone (Allopregnanolone)IBA 01/2022 - 08/2012
2	HMGB1 Protein (HMG1)IBA 01/2022 - 01/2018
2	ST 1435IBA 01/2021 - 11/2014
2	steroidogenic acute regulatory proteinIBA 11/2018 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2018 - 01/2018
2	CytokinesIBA 03/2016 - 07/2009
2	Amyloid (Amyloid Fibrils)IBA 10/2011 - 12/2010
2	Bromodeoxyuridine (BrdU)IBA 09/2011 - 12/2010
2	Myelin Basic ProteinIBA 01/2010 - 01/2008
2	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 07/2009 - 02/2007
2	Adenosine Triphosphatases (ATPase)IBA 07/2009 - 02/2005
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 07/2009 - 02/2009
2	Arginine Vasopressin (Argipressin)IBA 04/2008 - 01/2004
2	MineralocorticoidsIBA 04/2008 - 01/2004
2	NeuropeptidesIBA 03/2005 - 01/2004
1	InflammasomesIBA 01/2022
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	tiboloneIBA 01/2022
1	Estrogen ReceptorsIBA 07/2020
1	GTP-Binding Proteins (G-Protein)IBA 07/2020
1	CORT113176IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	IsomerasesIBA 11/2018
1	Voltage-Dependent Anion ChannelsIBA 11/2018
1	CuprizoneIBA 11/2018
1	Oxidoreductases (Dehydrogenase)IBA 11/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2018
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 03/2016
1	Biological ProductsIBA 01/2016
1	Aromatase (CYP19)IBA 02/2015
1	CORT 108297IBA 09/2014
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 12/2013
1	Therapeutic UsesIBA 12/2013
1	GABA-A Receptors (GABA(A) Receptor)IBA 08/2013
1	Progesterone CongenersIBA 08/2012
1	LigandsIBA 08/2012
1	Aminobutyrates (Aminobutyric Acid)IBA 08/2012
1	progesterone receptor AIBA 08/2012

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2019
2	Contraception (Birth Control) 01/2019 - 08/2012
2	Injections 01/2016 - 01/2011
1	Immunomodulation 11/2015